Published 29 September 2008, doi:10.1136/bmj.a1530
Cite this as: BMJ 2008;337:a1530

Practice

Guidelines

Early identification and management of chronic kidney disease: summary of NICE guidance

Emily Crowe, research fellow1, David Halpin, consultant physician & honorary senior clinical lecturer2, Paul Stevens, consultant nephrologist3, on behalf of the Guideline Development Group

1 National Collaborating Centre for Chronic Conditions, Royal College of Physicians, London , 2 Royal Devon & Exeter Hospital, Exeter, 3 Kent and Canterbury Hospital, Canterbury CT1 3NG

Correspondence to: P Stevens paul.stevens@ekht.nhs.uk

The first 150 words of the full text of this article appear below.

Chronic kidney disease is associated with substantial comorbidity including hypertension, cardiovascular disease, anaemia, and renal bone disease. People with chronic kidney disease have a far greater likelihood of cardiovascular death than progression to established renal failure (requiring dialysis or kidney transplantation).1 2 3 4 Chronic kidney disease has been highlighted as a public health problem through the international adoption of the US National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative staging system and because the prevalence of the disease as defined by the staging system has risen from 10% (in 1988-94) to 13% (in 1999-2004) of the non-institutionalised adult US population.5 6 7 The staging system (which comprises five stages, 1-5) defines chronic kidney disease on the basis of either evidence of kidney damage (proteinuria, haematuria, or anatomical abnormality) or an impaired glomerular filtration rate <60 ml/min/1.73 m2, present on at least two occasions over three months or longer. The use of a threshold . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Ahmed, A. K., Kamath, N. S., El Kossi, M., El Nahas, A. M. (2009). The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease. Nephrol Dial Transplant 0: gfp511v1-gfp511 [Abstract] [Full text]  
  • Cheung, C. K., Bhandari, S. (2009). Perspectives on eGFR reporting from the Interface between Primary and Secondary Care. CJASN 4: 258-260 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Measuring proteinuria: albumin or total protein?
Mark S MacGregor
bmj.com, 5 Oct 2008 [Full text]
measuring proteinuria
Charles Heatley
bmj.com, 7 Oct 2008 [Full text]
NICE Guidance on CKD
Christopher G Winearls, et al.
bmj.com, 20 Oct 2008 [Full text]
Time to differentiate 'function' from 'disease'.
Malvinder S Parmar
bmj.com, 31 Oct 2008 [Full text]
Definition of Non Visible Haematuria
Des Ling
bmj.com, 2 Dec 2008 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ